Travere Therapeutics Inc (TVTX)

Stock price, financials, and technical signals for Travere Therapeutics Inc (TVTX).

$22.91

-0.81

(-3.41%)

As of 02/14/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

TVTX Performance Snapshot


1-Week Chg

5.33%

1-Month Chg

34.21%

3-Month Chg

24.04%

6-Month Chg

168.58%

1-Year Chg

177.70%

Year-To-Date Chg

20.77%

Beta 1-Year

1.46

Beta 5-Year

0.75

Volatility (10-Day)

5.30%

TVTX Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-02-14

$22.91

-$0.81 (-3.41%)

$24

$24.14

$22.82

$23.29

1.24M ($28.30M)

2025-02-13

$23.72

$0.52 (2.24%)

$23.06

$24.13

$22.87

$23.57

1.88M ($44.70M)

2025-02-12

$23.20

-$0.55 (-2.32%)

$23.53

$24.28

$22.62

$23.37

2.79M ($64.67M)

2025-02-11

$23.75

$2.65 (12.56%)

$24.07

$25.29

$23.01

$24.02

6.41M ($152.23M)

2025-02-10

$21.10

-$0.65 (-2.99%)

$21.68

$21.68

$20.29

$21.02

1.80M ($37.90M)

2025-02-07

$21.75

-$0.11 (-0.5%)

$21.90

$22.25

$21.49

$21.83

2.44M ($53.12M)

2025-02-06

$21.86

$0.65 (3.06%)

$21.34

$22.13

$21.27

$21.75

2.54M ($55.58M)

2025-02-05

$21.21

$0.11 (0.52%)

$21.06

$21.86

$20.67

$21.25

1.47M ($31.18M)

2025-02-04

$21.10

$0.88 (4.35%)

$20.11

$21.20

$20.06

$20.79

987.26K ($20.83M)

2025-02-03

$20.22

-$0.24 (-1.17%)

$19.78

$20.57

$19.67

$20.15

1.22M ($24.64M)

TVTX Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $36.41M

    -74.76%

  • Total assets

    $504.41M

    -39.44%

  • Total liabilities

    $534.86M

    -3.29%

  • Total investments

    $241.03M

    -50.85%

  • Shareholders' equity

    -$30.45M

    -110.89%

  • Book value per share

    -$0.39

    -110.69%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $62.90M

    69.56%

  • Net income

    -$54.81M

    -136.36%

  • Operating expense

    $117.42M

    -8.54%

  • Gross profit

    $61.27M

    71.12%

  • EBITDA

    -$40.88M

    -125.68%

  • Earnings per share

    -$0.70

    -135.53%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    $4.12M

    -94.39%

  • Cash from operations

    -$42.51M

    28.12%

  • Cash from investing

    $46.13M

    -65.40%

  • Cash from financing

    $46.00K

    107.26%

  • Free cash flow

    -$50.70M

    21.63%

  • Free cash flow per share

    -$0.65

    23.11%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $1.07B

    59.58%

  • Enterprise value

    $1.44B

    43.26%

  • Shares outstanding

    76.49M

    1.97%

  • Profit margin

    -87.10%

    -121.44%

  • Gross margin

    97.40%

    0.93%

  • EBITDA margin

    -65.00%

    -115.15%


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    1.71

    -65.28%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.